Actuate Therapeutics Inc.

NASDAQ:ACTU   4:00:00 PM EDT
6.95
-0.18 (-2.52%)
7:07:52 PM EDT: $7.18 +0.23 (+3.31%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Actuate Therapeutics Inc. Stock, NASDAQ:ACTU

1751 River Run, Suite 400, Fort Worth, Texas 76107
Phone: +1.817.887.8455
Number of Employees:
http://www.actuatetherapeutics.com

Description

Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX.